Skip to main content
. 2022 Dec 13;23(24):15784. doi: 10.3390/ijms232415784

Figure 7.

Figure 7

Mice with hADC-overexpressing mNPCs (hADC-mNPCs) exhibit improved motor performances and bladder function recovery. (A) Basso Mouse Scale (BMS) score up to 6 weeks after SCI, demonstrating continuous improvement in the hADC-mNPC group compared with other groups at 4, 5, and 6 weeks. (B) Comparison of bladder residual urine volumes up to 14 days post-SCI, showing that levels were lower in hADC-mNPC mice than in other mice. Data are presented as means ± SEM. (n = 10−40 per group, O p < 0.05, OO p < 0.01, OOO p < 0.001 (hADC-mNPCs versus vehicle), # p < 0.05, ## p < 0.01 (hADC-mNPCs versus mNPCs), ** p < 0.01 (hADC-mNPCs versus pLXSN-mNPCs).